Alnylam Pharmaceuticals Inc (ALNY)

12:21 PM

Alnylam receives subpoena from US Attorney's Office amid strong Q3 earnings - The Business Journals

12:21 PM

10:41 AM

Alnylam (ALNY) Reports Strong Q3 Revenues and Raises Future Guidance - GuruFocus

10:41 AM

10:30 AM

Compared to Estimates, Alnylam (ALNY) Q3 Earnings: A Look at Key Metrics - Yahoo! Finance Singapore

10:30 AM

09:36 AM

Alnylam Pharmaceuticals, Inc. Revises Earnings Guidance for the Year 2025 - MarketScreener

09:36 AM

09:22 AM

Alnylam Pharmaceuticals : Q3 2025 Earnings Presentation - MarketScreener

09:22 AM

09:04 AM

Alnylam Pharmaceuticals Surpasses Q3 2025 Estimates with $1.84 E - GuruFocus

09:04 AM

08:45 AM

Alnylam Pharma shares fall 4% despite strong Q3 results and raised guidance - Investing.com Canada

08:45 AM

08:30 AM

Alnylam Pharmaceuticals Swings to Q3 Non-GAAP Earnings, Revenue Increases - MarketScreener

08:30 AM

08:24 AM

Alnylam: Q3 Earnings Snapshot - News-Times

08:24 AM

08:23 AM

ALNYLAM PHARMACEUTICALS, INC. SEC 10-Q Report - TradingView

08:23 AM

08:00 AM

Alnylam Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Period Progress - Business Wire

08:00 AM

07:18 AM

Why global investors buy Alnylam Pharmaceuticals Inc. (DUL) stockWeekly Stock Analysis & AI Optimized Trading Strategy Guides - newser.com

07:18 AM

06:50 AM

How dovish Fed policy supports Alnylam Pharmaceuticals Inc. (DUL) stock2025 Major Catalysts & Weekly Sector Rotation Insights - newser.com

06:50 AM

05:20 AM

Is Alnylam Pharmaceuticals Inc. reversing from oversold territoryProduct Launch & Reliable Entry Point Alerts - newser.com

05:20 AM

05:11 AM

Alnylam Pharmaceuticals, Inc. $ALNY Shares Bought by Teacher Retirement System of Texas - MarketBeat

05:11 AM

04:35 AM

Combining machine learning predictions for Alnylam Pharmaceuticals Inc.Trade Risk Summary & Technical Buy Zone Confirmations - newser.com

04:35 AM

Oct 29, 2025

How to recover losses in Alnylam Pharmaceuticals Inc. stockPortfolio Value Summary & Accurate Trade Setup Notifications - newser.com

Oct 29, 2025

Oct 29, 2025

Is Alnylam Pharmaceuticals Inc. (DUL) stock vulnerable to rate hikesWatch List & Free Expert Verified Stock Movement Alerts - newser.com

Oct 29, 2025

Oct 29, 2025

Amgen's Q3 Earnings in the Cards: Here's What to Expect - The Globe and Mail

Oct 29, 2025

Oct 29, 2025

How Recent Momentum and Analyst Upgrades Are Shaping Alnylam’s Evolving Investment Story - Yahoo Finance

Oct 29, 2025

Oct 29, 2025

How to monitor Alnylam Pharmaceuticals Inc. with trend dashboardsQuarterly Market Summary & Stepwise Entry and Exit Trade Signals - newser.com

Oct 29, 2025

Oct 29, 2025

What data driven models say about Alnylam Pharmaceuticals Inc.’s futureJuly 2025 Reactions & Free Daily Entry Point Trade Alerts - newser.com

Oct 29, 2025

Oct 29, 2025

RNAi Technology Market See Incredible Growth 2025-2032 | Alnylam Pharmaceuticals, OriGene Technologies, Inc. - openPR.com

Oct 29, 2025

Oct 29, 2025

Motley Fool Asset Management LLC Grows Stock Holdings in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat

Oct 29, 2025

Oct 29, 2025

Alnylam Pharmaceuticals, Inc. $ALNY Shares Acquired by Wealthfront Advisers LLC - MarketBeat

Oct 29, 2025

Oct 29, 2025

Can Alnylam Pharmaceuticals Inc. (DUL) stock sustain revenue momentumPortfolio Update Summary & Real-Time Chart Pattern Alerts - newser.com

Oct 29, 2025

Oct 29, 2025

How risky is Alnylam Pharmaceuticals Inc. (DUL) stock compared to peersJuly 2025 Macro Moves & Entry and Exit Point Strategies - newser.com

Oct 29, 2025

Oct 29, 2025

Will Alnylam Pharmaceuticals Inc. continue its uptrendJuly 2025 Update & Free Long-Term Investment Growth Plans - newser.com

Oct 29, 2025

Oct 29, 2025

What RSI levels show for Alnylam Pharmaceuticals Inc. (DUL) stock2025 Market WrapUp & Accurate Trade Setup Notifications - newser.com

Oct 29, 2025

Oct 28, 2025

PD-1 and PD-L1 Inhibitors Clinical Landscape, Key Companies, Therapeutic Evaluation, Treatment Approaches, and Pipeline Insights | Hoffmann-La Roche, PTC Therapeutics, Annexon, Alnylam Pharmaceuticals - Barchart.com

Oct 28, 2025

Oct 28, 2025

Bevacizumab: Clinical Overview, Key Companies, Therapeutic Insights, Treatment Strategies, and Pipeline Analysis | Hoffmann-La Roche, PTC Therapeutics, Annexon, Alnylam Pharmaceuticals, Neuvivo, BPG B - Barchart.com

Oct 28, 2025

Oct 28, 2025

Why Alnylam Pharmaceuticals Inc. stock is recommended by analystsWeekly Trend Summary & Comprehensive Market Scan Insights - newser.com

Oct 28, 2025

Oct 28, 2025

Is Alnylam Pharmaceuticals Inc. stock dividend yield sustainableQuarterly Earnings Report & Weekly High Conviction Trade Ideas - Fundação Cultural do Pará

Oct 28, 2025

Oct 28, 2025

Exploring Analyst Estimates for Alnylam (ALNY) Q3 Earnings, Beyond Revenue and EPS - Yahoo! Finance UK

Oct 28, 2025

Oct 28, 2025

Hypertension Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Addpharma Inc., Alnylam Therapeutics, ORPHAI THERAPEUTICS, 35Pharma Inc - Barchart.com

Oct 28, 2025

Oct 28, 2025

Alnylam Pharmaceuticals (ALNY) extending rally in final stage from April-2025 low - FXStreet

Oct 28, 2025

Oct 28, 2025

What downside risks could hit Alnylam Pharmaceuticals Inc. (DUL) stock2025 Volatility Report & Free Weekly Watchlist of Top Performers - newser.com

Oct 28, 2025

Oct 28, 2025

Convergence Investment Partners LLC Acquires New Position in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat

Oct 28, 2025

Oct 28, 2025

Can Alnylam Pharmaceuticals Inc. (DUL) stock sustain institutional flows2025 Trading Recap & Stock Portfolio Risk Control - newser.com

Oct 28, 2025

Oct 28, 2025

Is it time to cut losses on Alnylam Pharmaceuticals Inc.Treasury Yields & Smart Investment Allocation Insights - newser.com

Oct 28, 2025

Oct 27, 2025

What to do if you’re stuck in Alnylam Pharmaceuticals Inc.Trade Ideas & Weekly Top Gainers Trade List - newser.com

Oct 27, 2025